Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxycodone + Dexmedetomidine vs Remifentanil + Dexmedetomidine in Elderly Severe Pneumonia Patients on Mechanical Ventilation
ChiCTR2500108469Phase 4Recruiting
- Sponsor
- Shenyang 242 Hospital
- Start
- Sep 2025
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in pneumonia, delirium and agitation comparing oxycodone + dexmedetomidine with Control: remifentanil + dexmedetomidine (2 arms). Primary endpoint: Incidence of delirium within 72 hours. Started Sep 2025; status: recruiting.
02
Drugs
oxycodoneremifentanildexmedetomidine
03
Conditions
pneumoniadeliriumagitation
Beyond the preview
Go deeper on ChiCTR2500108469.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500108469.